Internal Medicine, Rheumatology · Brockton, MA
NPI
1336115666
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1351 Main St
Brockton, MA, 02301
Phone (508) 587-4112
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
186,491 services
Medicare patients, 2024
610
Average age 74
Drug cost, 2024
$4.5M
3,821 prescriptions
Company payments, 2025
$197
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ari J Schwartz was code J1602 (injection, golimumab, 1 mg, for intravenous use), 57,000 times for 71 patients. In total Ari J Schwartz billed 186,491 services in 37 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 57,000 | 71 | $9.07 | $517K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 47,600 | 19 | $3.60 | $171K |
| J3262 Injection, tocilizumab, 1 mg | Office | 41,088 | 13 | $4.69 | $193K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,550 | 14 | $33.85 | $357K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 7,770 | 12 | $8.59 | $67K |
| J9312 Injection, rituximab, 10 mg | Office | 5,060 | 21 | $61.32 | $310K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,823 | 37 | $0.08 | $216 |
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 28 | $20.60 | $57K |
| 99214 Office E&M - Established | Office | 738 | 378 | $103.33 | $76K |
| 96413 Chemotherapy Administration | Office | 696 | 125 | $113.20 | $79K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 544 | 15 | $0.21 | $113 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 537 | 111 | $0.47 | $253 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 398 | 258 | $13.63 | $5,423 |
| 96401 Chemotherapy Administration | Office | 277 | 60 | $62.37 | $17K |
| 99213 Office E&M - Established | Office | 274 | 208 | $72.43 | $20K |
By year: 2022 $1.7M for 105,389 services; 2023 $2.0M for 154,756 services; 2024 $2.1M for 186,491 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ari J Schwartz prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 727 prescriptions and refills. In total Ari J Schwartz wrote 3,821 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 727 | 1,664 | 171 | $27K |
| Prednisone Generic | 487 | 619 | 150 | $4,223 |
| Hydroxychloroquine Sulfate Generic | 261 | 639 | 70 | $12K |
| Enbrel Sureclick Etanercept | 256 | 270 | 30 | $2.0M |
| Allopurinol Generic | 248 | 685 | 71 | $3,190 |
| Meloxicam Generic | 211 | 415 | 53 | $556 |
| Gabapentin Generic | 163 | 339 | 38 | $3,541 |
| Leflunomide Generic | 141 | 362 | 40 | $12K |
| Celecoxib Generic | 117 | 221 | 32 | $1,662 |
| Methylprednisolone Generic | 103 | 105 | 33 | $762 |
| Tramadol Hcl Generic | 85 | 91 | Under 11 | $683 |
| Amitriptyline Hcl Generic | 75 | 195 | 19 | $1,746 |
| Folic Acid Generic | 52 | 125 | 16 | $562 |
| Humira(Cf) Pen Adalimumab | 50 | 50 | Under 11 | $529K |
| Simponi Golimumab | 45 | 53 | Under 11 | $325K |
Brand drugs: - claims; generic drugs: 3,165 claims; opioid claims: 101.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ari J Schwartz $197 ($197 in general payments such as food, travel and fees) from 4 companies. The largest payer was Janssen Biotech, Inc. with $99.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.